Encapsulating peritoneal sclerosis in paediatric peritoneal dialysis patients: The experience of the Italian Registry of Pediatric Chronic Dialysis

Nephrology Dialysis Transplantation

Volumn 28, Issue 6, 2013, Pages 1603-1609

  Vidal, Enrico ^a   Edefonti, Alberto ^b   Puteo, Flora ^c   Chimenz, Roberto ^d   Gianoglio, Bruno ^e   Lavoratti, Giancarlo ^f   Leozappa, Giovanna ^g   Maringhini, Silvio ^h   Mencarelli, Francesca ⁱ   Pecoraro, Carmine ^j   Ratsch, Ilse Maria ^k   Cannavò, Rossella ^l   De Palo, Tommaso ^c   Testa, Sara ^b   Murer, Luisa ^a   Verrina, Enrico ^l  

^a UNIVERSITY OF PADOVA   (Italy)

^b FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^c Giovanni XXIII Children's Hospital   (Italy)

^d UNIVERSITY OF MESSINA   (Italy)

^e REGINA MARGHERITA CHILDREN S HOSPITAL   (Italy)

^f UNIVERSITY OF FLORENCE   (Italy)

^g BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^h Ospedale dei Bambini G Di Cristina   (Italy)

ⁱ UNIVERSITY OF BOLOGNA   (Italy)

^j SANTOBONO PAUSILIPON CHILDREN S HOSPITAL   (Italy)

^k UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^l G GASLINI INSTITUTE   (Italy)

more..

Author keywords

Children; Encapsulating peritoneal sclerosis; Peritoneal dialysis

Indexed keywords

AZATHIOPRINE; CALCINEURIN INHIBITOR; CORTICOSTEROID; CYCLOSPORIN A; MYCOPHENOLIC ACID; PREDNISONE; RAPAMYCIN; TACROLIMUS; TAMOXIFEN;

ADOLESCENT; ARTICLE; CHILD; CLINICAL ARTICLE; CONGENITAL ANOMALY OF KIDNEY AND URINARY TRACT; CONGENITAL NEPHROTIC SYNDROME; FOCAL GLOMERULOSCLEROSIS; GLOMERULOPATHY; HEMODIALYSIS; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; INTESTINE OBSTRUCTION; ITALY; KIDNEY MALFORMATION; KIDNEY TRANSPLANTATION; LAPAROTOMY; MORTALITY; PERITONEAL DIALYSIS; PERITONEAL FIBROSIS; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; URINARY TRACT MALFORMATION;

CHILDREN; ENCAPSULATING PERITONEAL SCLEROSIS; PERITONEAL DIALYSIS;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; ITALY; MALE; PERITONEAL DIALYSIS; PERITONEAL FIBROSIS; PERITONITIS; PROGNOSIS; REGISTRIES; RENAL INSUFFICIENCY, CHRONIC; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE;

EID: 84879862161     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gft061     Document Type: Article

References (34)

1. Vidal E, Edefonti A, Murer L et al. Peritoneal dialysis in infants: the experience of the Italian Registry of Paediatric Chronic Dialysis. Nephrol Dial Transplant 2012; 27: 388-395
2. ERA-EDTA Registry: ERA-EDTA Registry Annual Report 2009. Amsterdam, The Netherlands: Academic Medical Center, Department of Medical Informatics, 2011. http://www.era-edta-reg. org/files/annualreports/pdf/AnnRep2009.pdf
3. Kawaguchi Y, Kawanishi H, Mujais S et al. Encapsulating peritoneal sclerosis: definition, etiology, diagnosis, and treatment. International Society for Peritoneal Dialysis Ad Hoc Committee on Ultrafiltration Management in Peritoneal Dialysis. Perit Dial Int 2000; 20(Suppl 4): S43-S55
4. Hoshii S, Honda M, Itami N et al. Sclerosing encapsulating peritonitis in pediatric peritoneal dialysis patients. Pediatr Nephrol 2000; 14: 275-279
5. Ekim M, Fitoz S, Yagmurlu A et al. Encapsulating peritoneal sclerosis in paediatric peritoneal dialysis patients. Nephrology 2005; 10: 341-343
6. Tan R, Betjes M, Cransberg K. Post-transplantation encapsulating peritoneal sclerosis in a young child. Nephrol Dial Transplant 2011; 26: 3822-3824
7. da Silva N, Rocha S, Rocha L et al. Post-transplantation encapsulating peritoneal sclerosis in a pediatric patient. Pediatr Nephrol 2012 Sep;27(9):1583-1588 (Epub ahead of print)
8. Korte MR, Boeschoten EW, Betjes MG. The Dutch EPS Registry: increasing the knowledge of encapsulating peritoneal sclerosis. Neth J Med 2009; 67: 359-362
9. Summers AM, Abrahams AC, Alscher MD et al. A collaborative approach to understanding EPS: the European prospective. Perit Dial Int 2011; 31: 245-248
10. Habib SM, Betjes MGH, Fieren MWJA et al. Management of encapsulating peritoneal sclerosis: a guideline on optimal and uniform treatment. Neth J Med 2011; 69: 500-507
11. Latus J, Ulmer C, Fritz P et al. Encapsulating peritoneal sclerosis: a rare, serious but potentially curable complication of peritoneal dialysis - experience of a referral centre in Germany. Nephrol Dial Transplant 2012 June 25 (Epub ahead of print)
12. Warady BA. Sclerosing encapsulating peritonitis: what approach should be taken with children? Perit Dial Int 2000; 20: 390-391
13. Tan FLS, Loh D, Prabhakaran K. Sclerosing encapsulating peritonitis in a child secondary to peritoneal dialysis. J Pediatr Surg 2005; 40: E21-E23
14. Korte MR, Habib SM, Lingsma H et al. Posttransplantation encapsulating peritoneal sclerosis contributes significantly to mortality after kidney transplantation. Am J Transplant 2011; 11: 599-605
15. Habib AM, Preston E, Davenport A. Risk factors for developing encapsulating peritoneal sclerosis in the icodextrin era of peritoneal dialysis prescription. Nephrol Dial Transplant 2010; 25: 1633-1638
16. Kawanishi H, Kawaguchi Y, Fukui H et al. Encapsulating peritoneal sclerosis in Japan: a prospective, controlled, multicentre study. Am J Kidney Dis 2004; 44: 729-737
17. Brown MC, Simpson K, Kerssens JJ et al. on behalf of the Scottish Renal Registry. Encapsulating peritoneal sclerosis in the new millennium: a national cohort study. Clin J Am Soc Nephrol 2009; 4: 1222-1229
18. Araki Y, Hataya H, Tanaka Y et al. Long-term peritoneal dialysis is a risk factor of sclerosing encapsulating peritonitis for children. Perit Dial Int 2000; 20: 445-451
19. SmitW, Shouten N, van der Berg N et al. for the Netherlands Ultrafiltration Failure Study Group. Analysis of the prevalence and causes of ultrafiltration failure during long-term peritoneal dialysis: a cross-sectional study. Perit Dial Int 2004; 24: 562-570
20. Williams JD, Craig KJ, Topley N et al. Peritoneal dialysis: changes to the structure of the peritoneal membrane and potential for biocompatible solutions. Kidney Int Suppl 2003; S158-S161
21. Warady BA, Alexander SR, Hossli S et al. Peritoneal membrane transport function in children receiving long-term dialysis. J Am Soc Nephrol 1996; 7: 2385-2391
22. Nomoto Y, Kawaguchi Y, Kubo H et al. Sclerosing encapsulating peritonitis in patients undergoing continuous ambulatory peritoneal dialysis: a report of the Japanese Sclerosing Encapsulating Peritonitis Study Group. Am J Kidney Dis 1996; 20: 420-427
23. Campbell S, Clarke P, Hawley C et al. Sclerosing peritonitis: identification of diagnostic, clinical, and radiological features. Am J Kidney Dis 1994; 24: 819-825
24. Augustine T, Brown PW, Davies SD et al. Encapsulating peritoneal sclerosis: clinical significance and implications. Nephron Clin Pract 2009; 111: c149-c154
25. Brown P, Baddeley H, Read AE et al. Sclerosing peritonitis, an unusual reaction to a beta-adrenergic-blocking drug (practolol). Lancet 1974; 2: 1477-1481
26. Marigold JH, Pounder RE, Pemberton J et al. Propranolol, oxprenolol, and sclerosing peritonitis. BMJ 1982; 284: 870
27. Fieren MWJA, Betjes MGH, Korte MR et al. Posttransplant encapsulating peritoneal sclerosis: a worrying new trend? Perit Dial Int 2007; 27: 619-624
28. Honda K, Oda H. Pathology of encapsulating peritoneal sclerosis. Perit Dial Int 2005; 25: S19-S29
29. Khanna A, Plummer M, Brombereck C et al. Expression of TGF- ? and fibrogenic genes in transplant recipients with tacrolimus and cyclosporine nephrotoxicity. Kidney Int 2002; 62: 2257-2263
30. Naiki Y, Maeda Y, Matsuo K et al. Involvement of TGF-? signal for peritoneal sclerosing in continuous ambulatory peritoneal dialysis. J Nephrol 2003; 16: 95-102
31. Margetts PJ, Kolb M, Galt T et al. Gene transfer of transforming growth factor-beta 1 to the rat peritoneum: effects on membrane function. J Am Soc Nephrol 2001; 12: 2029-2039
32. Kim JH, Kim BK, Moon KC et al. Activation of the TGF-beta/Smad signaling pathway in focal segmental glomerulosclerosis. Kidney Int 2003; 64: 1715-1721
33. D'Agati VD, Kaskel FJ, Falk RJ. Focal segmental glomerulosclerosis. N Engl J Med 2001; 365: 2398-2411
34. Pape L, Offner G, Kreuzer M et al. De novo therapy with everolimus, low-dose ciclosporine A, basiliximab and steroid elimination in pediatric kidney transplantation. Am J Transplant 2010; 10: 2349-2354